The 2008 metformin paper used spontaneously hypertensive rats that are inbred and develop high blood pressure, making them a non-representative animal model, whereas a 2016 Interventions Testing Program trial using genetically diverse mice showed no metformin benefit, undermining the preclinical case for metformin longevity use.
factualpending
Evidence Quote
“that 2008 paper used spontaneously hypertensive rats they are inbred and develop high blood pressure so in 2016 the interventions testing program trialled metformin but the difference here is that they used genetically diverse mice and there was no benefit whatsoever seen from metformin”
Created: 8/10/2026, 9:22:16 PM
Your notes
Loading notes...